Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK updates guidance for MoM hip patient follow-up with extended blood and MRI screening regime

This article was originally published in Clinica

Executive Summary

An estimated 49,000 UK patients with metal-on-metal (MoM) hip implants could face a life-time of annual check-ups after the country's Medicines and Healthcare products Regulatory Agency (MHRA) updated its April 2010 guidance on the follow-up protocol for these devices. The new guidance, which introduces a tighter blood testing and diagnostic imaging regime, is in response to growing concerns related to the risks posed by debris from wear and tear of these types of orthopaedic implants over time.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT039642

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel